Welcome to the e-CCO Library!

P242: Latent Tuberculosis: frequency of occurrence and effect on clinical, laboratory, endoscopic and morphological activity of the course Inflammatory Bowel Diseases
Year: 2022
Source: ECCO'22
Authors: Babayeva-Sadigova, G.(1,2);Makhmudov , U.(3);Asadova , G.(1,4);Quliyev , F.(4);Samadova , T.(1,4);Mirzazade, O.(1);Hasanova , A.(1);
Created: Friday, 11 February 2022, 3:52 PM
P242: Newly diagnosed Inflammatory Bowel Disease patients referred via the Straight To Test Lower GI two week wait pathway, Single Centre Study.
Year: 2021
Source: ECCO'21 Virtual
Authors: Samarasinghe, M.(1);Chariah, F.(1);Desilva, C.(1);Koutsoumpas, A.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P242: Performance of the BÜHLMANN Quantum Blue® Infliximab point-of-care assay dedicated for therapeutic drug monitoring of serum infliximab trough levels
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

T. Schuster*, E. Keller, S. Kräuchi, F. Bantleon, J. Weber, M. Schneider

Created: Friday, 22 February 2019, 9:49 AM
P242: Phenotypic characterisation of elderly – onset inflammatory bowel disease – IBD at the extremes
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Nosegbe U.*1, Scott J.A.2, Crooks B.2, Miller B.2, Limdi J.2,3

Created: Wednesday, 20 February 2019, 10:36 AM
P242: The prevalence of sarcopenia and its effect on prognosis in patients with Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

D.J. Oh1, H. Yoon1*, Y.J. Choi1, C.M. Shin1, Y.S. Park1, N. Kim1,2, D.H. Lee1,2

Created: Thursday, 21 February 2019, 9:14 AM
P242: Universal exclusion of patients with Permanent Ileostomy in Crohn's disease clinical trials: A systematic review
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Vuyyuru, S.(1);Solitano, V.(1);Nguyen, T.(2);Rieder, F.(3,4);Jairath, V.(1,2,5)*;
Created: Friday, 14 July 2023, 10:48 AM
P243 Changes in the therapeutic management of inflammatory bowel disease in the biological era – a nationwide retrospective cohort study in three Nordic countries: Results from the TRINordic study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Zhao1, M. Lördal2, E. Langholz3, T. Knudsen4, M. Voutilainen5, M.L. Høivik6, B. Moum7, B. Saebo8, P. Haiko9, C. Malmgren10, M. Coskun11, H.O. Melberg12, J. Burisch13

Created: Thursday, 30 January 2020, 10:12 AM
P243: Colectomy rates in ulcerative colitis are low and decreasing: Ten-year follow-up data from the Swiss IBD cohort study
Year: 2018
Source: ECCO '18 Vienna
Authors:

L. Parragi1, N. Fournier2, J. Zeitz3, M. Scharl1, T. Greuter1, P. Schreiner1, B. Misselwitz1, E. Safroneeva4, A. Schoepfer5, S.R. Vavricka6, G. Rogler1, L. Biedermann on behalf of the Swiss IBD Cohort Study Group7*

Created: Thursday, 21 February 2019, 9:14 AM
P243: Complications of newly diagnosed Crohn's disease can be predicted by mathematical modeling of serologic responses
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Yanai H.*1,2, Ben-Shachar S.2,3, Maharshak N.1,2, Ron Y.1,2, Leshno M.2,4, Dotan I.1,2

Created: Wednesday, 20 February 2019, 10:36 AM
P243: Developing a protocol to conduct a student-driven study across Europe: EuroSurg-1 study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

G. Pellino on behalf of EuroSurg Collaborative*

Created: Friday, 22 February 2019, 9:49 AM
P243: Elevated presepsin levels are a marker of sepsis risk in patients with inflammatory bowel diseases receiving therapy of TNF-α blockers.
Year: 2021
Source: ECCO'21 Virtual
Authors: Knyazev, O.(1,2,3);Kagramanova, A.(1);Lishchinskaya, A.(1);Li, I.(1);Noskova, K.(4);Fadeeva, N.(5);Subbotin, V.(1);Demchenko, A.(1);Babayan, A.(1);Zvyaglova, M.(1);Kulakov, D.(1,6);
Created: Wednesday, 2 June 2021, 4:12 PM
P243: Relationship between intestinal ultrasound, fecal calprotectin and Harvey-Bradshaw Index in the assessment of infllamatory activity in Cronh´s Disease
Year: 2022
Source: ECCO'22
Authors: Montero Moretón, Á.M.(1);Bastón Rey, I.(2);Calvino Suarez, C.(2);De la Iglesia García, D.(2);Ferreiro Iglesias, R.(2);Maestro Antolín, S.(1);Santos Santamarta, F.(1);Pérez Millán, A.G.(1);Dominguez-Munoz, E.(2);Barreiro-de Acosta, M.(2);
Created: Friday, 11 February 2022, 3:52 PM
P243: The association between serological markers ASCA and ANCA and response to induction treatment in therapy-naïve children with inflammatory bowel disease: an international prospective study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Klomberg, R.(1)*;Kaper, D.(1);Barendregt, D.(2);Vuijk, S.(1);Schreurs, M.(3);Charrout, M.(4);Ruemmele, F.(5);Kemos, P.(6);Croft, N.(6);Samsom, J.(2);de Ridder, L.(1);
Created: Friday, 14 July 2023, 10:48 AM
P243: The different role of histology in ulcerative colitis and Crohn’s disease: a retrospective study in a single referral centre
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. Pagnini*1, M. C. Di Paolo1, D. Campagna2, L. Costarelli2, F. Monardo2, F. R. Piro2, L. D'Alba1, M. A. De Cesare1, L. Pallotta1, R. Urgesi1, G. Villotti1, M. A. Vitale1, M. Giordano2, M. G. Graziani1

Created: Friday, 22 February 2019, 9:41 AM
P244 Validation of the Red Flags index for early diagnosis of Crohn’s disease: A prospective general practitioner study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

G. Fiorino1, D. Gilardi2, S. Bonovas1, A. Di Sabatino3, E. Angeli4, N. Gaffuri5, M. Allocca2, F. Furfaro2, G. Roda2, M. Lenti3, A. Nicola3, C. Mengoli3, L. Peyrin-Biroulet6, S. Danese1

Created: Thursday, 30 January 2020, 10:12 AM
P244: Clinician preferences in treating steroid resistant ulcerative colitis: a discrete-choice experiment (DCE) survey
Year: 2021
Source: ECCO'21 Virtual
Authors: Wickramasekera, N.(1);Shackley, P.(1);Coates, E.(1);Barr, A.(1);Lee, M.(2);Blackwell, S.(3);Bedford, H.(3);Dames, N.(3);Probert, C.(4);Sebastian, S.(5);Lobo, A.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P244: COVID-19 vaccine does not increase the likelihood of disease exacerbation in IBD: results from a population-based study
Year: 2022
Source: ECCO'22
Authors: Lev Zion, R.(1);Focht, G.(1);Lujan, R.(1);Mendelovici, A.(2);Friss, C.(1);Greenfeld, S.(3);Kariv, R.(4);Ben-Tov, A.(5,6);Matz, E.(7);Nevo, D.(8);Barak-Corren, Y.(9);Dotan, I.(10);Turner, D.(1);
Created: Friday, 11 February 2022, 3:52 PM
P244: Diffusion-weighted MRI enables to accurately grade inflammatory activity in patients of ileocolonic Crohn's disease: results from an observational study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Mao R.1, Li X.2, Li Z.2, Chen M.*1

Created: Wednesday, 20 February 2019, 10:36 AM
P244: Faecal calprotectin is a very reliable tool to predict and monitor the risk of relapse after therapeutic de-escalation in patients with inflammatory bowel diseases
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Buisson1,2*, W.Y. Mak3,4, M.J. Andersen Jr4, D. Lei4, S.A. Kahn4, J. Pekow4, R.D. Cohen4, N. Zmeter4, B. Pereira5, D.T. Rubin4

Created: Thursday, 21 February 2019, 9:14 AM
P244: Is prognostic utility of rapid faecal calprotectin test equal in all inflammatory bowel disease (IBD) subtypes? Retrospective analysis based on endoscopic indices
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Moniuszko*1, D. Koziel2, S. Gluszek2, G. Rydzewska1, 2

Created: Friday, 22 February 2019, 9:49 AM